Fig. 2From: Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospitalNumber of glaucoma classes used by subjects at baseline and after XEN placement (n = 15). The interquartile range is from 25 to 75%, as indicated by the respective upper and lower borders of the boxes. The adjacent limits are 1.5 times the upper and lower limits of the respective interquartile ranges. Blue dots represent outliers. Red dots represent the medianBack to article page